Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Neuro-Oncology|March 6, 2013
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized diseaseGabriele Calaminus, Rolf Kortmann, Jennifer Worch, et al.Bulletin Du Cancer|September 25, 2025
[Epidemiology of paediatric cancers in French-speaking Africa. The GFAOP hospital register]Brenda Mallon, Aissata Barry, Rolande Kabore, et al.Oncogene|August 8, 2002
Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumourDominique Baudry, Marine Faussillon, Marie-Odile Cabanis, et al.Journal of Global Oncology|December 4, 2019
Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie PédiatriqueGabrielle C Bouda, Fousseyni Traoré, Line Couitchere, et al.Journal of Global Oncology|September 6, 2019
Treatment of Wilms Tumor in Sub-Saharan Africa: Results of the Second French African Pediatric Oncology Group StudyAtteby Jean-Jacques Yao, Claude Moreira, Fousseyni Traoré, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric OncologyLaurence Brugières, Helene Pacquement, Marie-Cecile Le Deley, et al.Blood|November 30, 2006
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Anne Auperin, Mary Gerrard, et al.JCO Global Oncology|August 9, 2020
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future PerspectivesJaques van Heerden, Mohamed Zaghloul, Anouk Neven, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 studyMitchell S Cairo, Richard Sposto, Mary Gerrard, et al.Haematologica|March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant studyAnne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.Pageof 9